Evidence map›Paper›PMID 18388180›Full record

ArticleBlood2008

Efficient transduction of pigtailed macaque hematopoietic repopulating cells with HIV-based lentiviral vectors.

Grant D Trobridge, Brian C Beard, Christina Gooch, Martin Wohlfahrt, Philip Olsen, James Fletcher, Punam Malik, Hans-Peter Kiem

Abstract read
In one paragraph

Article in Blood, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed.

  1. Engraftment and persistence ofScience translational medicine · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Understanding and overcoming adverse consequences of genome editing on hematopoietic stem and progenitor cells.Molecular therapy : the journal of the American Society of Gene Therapy · 2021
    Review
  6. Human gene therapy · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Grant D TrobridgeClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA.
Brian C Beard
Christina Gooch
Martin Wohlfahrt
Philip Olsen
James Fletcher
Punam Malik
Hans-Peter Kiem

Funding

VECTOR CONSTRUCTIONS FOR GENE THERAPY OF SICKLE CELL DISEASEP01HL053750 · NHLBI · UNIVERSITY OF WASHINGTON · PI STAMATOYANNOPOULOS, GEORGE · 1994 to 2014
$30.4M
CORE--VECTOR PRODUCTIONP30DK056465 · NIDDK · FRED HUTCHINSON CANCER RESEARCH CENTER · PI HEIMFELD, SHELLY · 1999 to 2014
$14.9M
PILOT STUDY--RETROVIRUS MEDIATED TRANSFER OF HUMAN GLUCOCEREBROSIDASE GENEP30DK047754 · NIDDK · UNIVERSITY OF WASHINGTON · PI MILLER, ARTHUR DUSTY · 1994 to 2008
$8.4M
Suplement to Safety and Efficacy of AIDS Gene Therapy in MonkeysP01AI061839 · NIAID · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI ROSSI, JOHN JOSEPH · 2004 to 2007
$7.1M
Efficacy and Safety of Foamy Retroviral Vectors for AIDS Gene TherapyR21AI063959 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI TROBRIDGE, GRANT D · 2006 to 2007
$511k
NHLBI NIH HHS HL53750NHLBI NIH HHS P01 HL053750NIAID NIH HHS AI061839NIAID NIH HHS AI063959NIAID NIH HHS P01 AI061839NIAID NIH HHS R21 AI063959NIDDK NIH HHS DK47754NIDDK NIH HHS DK56465NIDDK NIH HHS P30 DK047754NIDDK NIH HHS P30 DK056465
6 · The paper itself

Abstract

Lentiviral vectors are attractive for hematopoietic stem cell (HSC) gene therapy because they do not require mitosis for nuclear entry, they efficiently transduce hematopoietic repopulating cells, and self-inactivating (SIN) designs can be produced at high titer. Experiments to evaluate HIV-derived lentiviral vectors in nonhuman primates prior to clinical trials have been hampered by low transduction frequencies due in part to host restriction by TRIM5alpha. We have established conditions for efficient transduction of pigtailed macaque (Macaca nemestrina) long-term repopulating cells using VSV-G-pseudotyped HIV-based lentiviral vectors. Stable, long-term, high-level gene marking was observed in 3 macaques using relatively low MOIs (5-10) in a 48-hour ex vivo transduction protocol. All animals studied had rapid neutrophil engraftment with a median of 10.3 days to a count greater than 0.5 x 10(9)/L (500/microL). Expression was detected in all lineages, with long-term marking levels in granulocytes at approximately 20% to 30%, and in lymphocytes at approximately 12% to 23%. All animals had polyclonal engraftment as determined by analysis of vector integration sites. These data suggest that lentiviral vectors should be highly effective for HSC gene therapy, particularly for diseases in which maintaining the engraftment potential of stem cells using short-term ex vivo transduction protocols is critical.

Indexed as

Genetic VectorsAnimalsAntigens, CD34Cell LineageGene ExpressionGenetic TherapyGraft SurvivalHematopoietic Stem CellsHematopoietic Stem Cell TransplantationHIV-1In Vitro TechniquesLentivirusMacaca nemestrinaTransduction, GeneticTransgenesAntigens, CD34

Identifiers

PMID18388180
PMCPMC2424151

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.